127 related articles for article (PubMed ID: 30775237)
1. HPV
Kim G; Taye J; Yu K; Park S; Kim J; Kim S; Lee D; Wang HY; Park KH; Lee H
Anal Cell Pathol (Amst); 2019; 2019():9365654. PubMed ID: 30775237
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR assays on formalin-fixed paraffin-embedded cervical tissue specimens from women with cervical cancer.
Wang HY; Kim G; Cho H; Kim S; Lee D; Park S; Park KH; Lee H
Exp Mol Pathol; 2015 Jun; 98(3):510-6. PubMed ID: 25835783
[TBL] [Abstract][Full Text] [Related]
3. Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors.
Wang HY; Park S; Kim S; Lee D; Kim G; Kim Y; Park KH; Lee H
Am J Clin Pathol; 2015 Mar; 143(3):344-51. PubMed ID: 25696792
[TBL] [Abstract][Full Text] [Related]
4. Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.
Li F; Cui J
Med Oncol; 2015 Jul; 32(7):199. PubMed ID: 26067630
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.
Yao YL; Tian QF; Cheng B; Cheng YF; Ye J; Lu WG
J Zhejiang Univ Sci B; 2017 Mar.; 18(3):256-262. PubMed ID: 28271661
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic poly(A) binding proteins regulate telomerase activity and cell growth in human papillomavirus type 16 E6-expressing keratinocytes.
Katzenellenbogen RA; Vliet-Gregg P; Xu M; Galloway DA
J Virol; 2010 Dec; 84(24):12934-44. PubMed ID: 20943973
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.
Wang HY; Kim H; Park KH
Int J Infect Dis; 2019 Jan; 78():22-30. PubMed ID: 30248464
[TBL] [Abstract][Full Text] [Related]
9. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker.
Fontecha N; Basaras M; Hernáez S; Andía D; Cisterna R
BMC Cancer; 2016 Nov; 16(1):852. PubMed ID: 27816058
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
12. Performance of HPV E6/E7 mRNA RT-qPCR for screening and diagnosis of cervical cancer with ThinPrep Pap test samples.
Munkhdelger J; Kim G; Wang HY; Lee D; Kim S; Choi Y; Choi E; Park S; Jin H; Park KH; Lee H
Exp Mol Pathol; 2014 Oct; 97(2):279-84. PubMed ID: 25102300
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of type-specific oncogenic human papillomavirus infection assessed by HPV E6/E7 mRNA among women with high-grade cervical lesions.
Wang HY; Park S; Lee D; Kim S; Kim G; Park KH; Lee H
Int J Infect Dis; 2015 Aug; 37():135-42. PubMed ID: 26141414
[TBL] [Abstract][Full Text] [Related]
14. Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions.
Yoshida T; Sano T; Kanuma T; Owada N; Sakurai S; Fukuda T; Nakajima T
Int J Gynecol Cancer; 2008; 18(1):121-7. PubMed ID: 17506843
[TBL] [Abstract][Full Text] [Related]
15. NFX1-123 is highly expressed in cervical cancer and increases growth and telomerase activity in HPV 16E6 expressing cells.
Vliet-Gregg PA; Robinson KL; Levan J; Matsumoto LR; Katzenellenbogen RA
Cancer Lett; 2019 May; 449():106-113. PubMed ID: 30776478
[TBL] [Abstract][Full Text] [Related]
16. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
[TBL] [Abstract][Full Text] [Related]
17. Expression of HPV-16 E6 protein and p53 inactivation increases the uterine cervical cancer invasion.
Yang X; Lu L
Drug Res (Stuttg); 2015 Feb; 65(2):70-3. PubMed ID: 24831244
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix.
Munkhdelger J; Choi Y; Lee D; Kim S; Kim G; Park S; Choi E; Jin H; Jeon BY; Lee H; Park KH
Diagn Microbiol Infect Dis; 2014 Aug; 79(4):422-7. PubMed ID: 24856365
[TBL] [Abstract][Full Text] [Related]
19. Correlation of hTERT Expression with Cervical Cytological Abnormalities and Human Papillomavirus Infection.
Zejnullahu VA; Zejnullahu VA; Josifovska S; Vukovik N; Pakovski K; Panov S
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Dec; 38(3):143-151. PubMed ID: 29668478
[TBL] [Abstract][Full Text] [Related]
20. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
